Aarti Drugs trades jubilantly on commencing new R&D center at MIDC Tarapur

05 May 2014 Evaluate

Aarti Drugs is currently trading at Rs. 430.00, up by 17.65 points or 4.28% from its previous closing of Rs. 412.35 on the BSE.

The scrip opened at Rs. 416.00 and has touched a high and low of Rs. 451.00 and Rs. 416.00 respectively. So far 89311 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 451.00 on 05-May-2014 and a 52 week low of Rs. 165.00 on 24-Sep-2013.

Last one week high and low of the scrip stood at Rs. 451.00 and Rs. 350.50 respectively. The current market cap of the company is Rs. 526.72 crore.

The promoters holding in the company stood at 59.61% while Institutions and Non-Institutions held 0.01% and 40.37% respectively.

Aarti Drugs has commenced the new R&D center at MIDC Tarapur. Earlier, on September 26, 2013  US health regulator had issued a warning letter to company's Maharashtra facilities. The investigators of the US Food and Drug Administration had identified significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals and active pharmaceutical ingredients at the companies Maharashtra facilities.

Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs Share Price

416.55 4.70 (1.14%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×